Interpreting T-Cell Cross-reactivity through Structure: Implications for TCR-Based Cancer Immunotherapy
Immunotherapy has become one of the most promising avenues for cancer treatment, making use of the patient’s own immune system to eliminate cancer cells. Clinical trials with T-cell-based immunotherapies have shown dramatic tumor regressions, being effective in multiple cancer types and for many dif...
Main Authors: | Dinler A. Antunes, Maurício M. Rigo, Martiela V. Freitas, Marcus F. A. Mendes, Marialva Sinigaglia, Gregory Lizée, Lydia E. Kavraki, Liisa K. Selin, Markus Cornberg, Gustavo F. Vieira |
---|---|
Format: | Article |
Language: | English |
Published: |
Frontiers Media S.A.
2017-10-01
|
Series: | Frontiers in Immunology |
Subjects: | |
Online Access: | http://journal.frontiersin.org/article/10.3389/fimmu.2017.01210/full |
Similar Items
-
Editorial: Quantification and prediction of T-cell cross-reactivity through experimental and computational methods
by: Dinler A. Antunes, et al.
Published: (2024-02-01) -
The Enigmatic Nature of the TCR-pMHC Interaction: Implications for CAR-T and TCR-T Engineering
by: D. V. Shevyrev, et al.
Published: (2022-11-01) -
Bench, bedside, toolbox: T-cells deliver on every level.
by: Bruno eLaugel
Published: (2014-02-01) -
Using molecular dynamics simulations to interrogate T cell receptor non-equilibrium kinetics
by: Zachary A. Rollins, et al.
Published: (2022-01-01) -
TCR/pMHC interaction: phenotypic model for an unsolved enigma
by: Jesus Galvez, et al.
Published: (2016-11-01)